Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

BioLife Solutions Inc (BLFS) USD0.001

Sell:$46.05 Buy:$53.90 Change: $0.69 (1.46%)
Market closed |  Prices as at close on 21 September 2021 | Switch to live prices |
Sell:$46.05
Buy:$53.90
Change: $0.69 (1.46%)
Market closed |  Prices as at close on 21 September 2021 | Switch to live prices |
Sell:$46.05
Buy:$53.90
Change: $0.69 (1.46%)
Market closed |  Prices as at close on 21 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. Its products include HypoThermosol FRS, CryoStor, BloodStor, Cell Thawing Media, PrepaStor and biologistex cold-chain management service.

Contact details

Address:
3303 Monte Villa Pkwy Ste 310
BOTHELL
98021-6200
United States
Telephone:
+1 (425) 4011400
Website:
https://biolifesolutions.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BLFS
ISIN:
US09062W2044
Market cap:
$1.93 billion
Shares in issue:
40.70 million
Sector:
Health Care Supplies
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Michael Rice
    Chairman of the Board, Chief Executive Officer
  • Maurice Tenney
    President, Chief Operating Officer
  • Roderick de Greef
    Chief Financial Officer
  • Aby Mathew
    Executive Vice President and Chief Scientific Officer
  • Todd Berard
    Chief Marketing Officer
  • Sarah Aebersold
    Vice President - Global Human Resources
  • Karen Foster
    Chief Quality Officer
  • Marcus Schulz
    Chief Revenue Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.